StockNews.com Begins Coverage on Nabriva Therapeutics (NASDAQ:NBRV)
Equities researchers at StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Trading Down 100.0 % The company has a quick ratio of 0.52, a current ratio of 0.85 and a […]
Equities researchers at StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Trading Down 100.0 % The company has a quick ratio of 0.52, a current ratio of 0.85 and a […]
